Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Approves Boxed Warning about Increased Risk of Blood Clots, Death with Xeljanz

americanpharmaceuticalreviewJuly 30, 2019

Tag: FDA , blood clots , Boxed Warning

PharmaSources Customer Service